PremiumThe FlySmith & Nephew price target raised to $28 from $27 at Canaccord Cautious Hold Rating on Smith & Nephew Amid Mixed Performance and Ambitious Targets Nuo Therapeutics enters Centrio distribution pact with Smith & Nephew PremiumThe FlySmith & Nephew opens door to break-up in response to activist, The Times says Smith & Nephew announces its efforts to develop technology in Spatial Surgery Smith & Nephew price target raised to 1,300 GBp from 1,250 GBp at Deutsche Bank PremiumRatingsSmith & Nephew Snats: Promising US Growth Amidst Chinese Market Challenges and Conservative Outlook Smith & Nephew: Hold Rating Amid Mixed FY25 Outlook and Challenges in China Smith & Nephew’s Strong Performance and Promising Outlook Reinforce Buy Rating 
